BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 13, 2010
View Archived Issues
DC-based TaReNef AIDS vaccine is safe and immunogenic in phase I/II trial
Read More
Pfizer's antibacterial MC-1 shows promising preclinical activity
Read More
Snapshots: Recent data on the antibacterial activity of CXA-101
Read More
First-in-human data disclosed on NIBR-6465
Read More
Pfizer introduces new candidates for inhalation therapy of COPD
Read More
Sigma-Tau describes new adenosine A2A receptor antagonists
Read More
Prosidion discloses new GPR119 receptor agonists
Read More
Phase I/II trials suggest efficacy of Neuvax vaccine in prevention of breast cancer recurrence
Read More
Auxilium begins phase III Xiaflex studies in Peyronie's disease
Read More
FDA sets date for end-of-phase II meeting on NTx-265
Read More
State University of New York, Albany claims novel antiestrogens
Read More
Exelixis and Bristol-Myers Squibb collaborate on multiple small-molecule programs
Read More
CureVac presents phase I/IIa data on CV-9103 in prostate cancer
Read More
GSK describes new tyrosine-protein kinase ITK/TSK inhibitors
Read More
Jazz Pharma receives FDA complete response letter regarding JZP-6 for fibromyalgia
Read More
FDA approves delayed-release risedronate sodium for postmenopausal osteoporosis
Read More
Researchers synthesize new oncolytic gold complexes
Read More
Novartis to use ImmunoGen's TAP technology to develop anticancer therapeutics
Read More
Seattle Genetics reports phase II data on brentuximab vedotin in lymphoma
Read More
ArQule and Daiichi Sankyo agree with FDA on SPA for phase III ARQ-197 trial
Read More
Novo Nordisk tenders all of its shares in ZymoGenetics to Bristol-Myers Squibb
Read More
FDA approves Vivitrol for prevention of relapse to opioid dependence
Read More
Phase III Multikine trial in head and neck cancer approved in Taiwan
Read More
Jubilant Organosys becomes Jubilant Life Sciences
Read More
Lundbeck acquires exclusive commercial rights to Sycrest outside U.S., China and Japan
Read More
